PUBLISHER: The Business Research Company | PRODUCT CODE: 1705417
PUBLISHER: The Business Research Company | PRODUCT CODE: 1705417
Montelukast Sodium Global Market Report 2025
Montelukast sodium functions as a leukotriene receptor antagonist, blocking the action of leukotrienes that induce asthma symptoms and allergic reactions. It is employed for managing and preventing asthma symptoms and alleviating seasonal and perennial allergic rhinitis. Typically, montelukast is administered orally in tablet form.
Montelukast sodium exists in several product types, including crystal-like, form-less, or amorphous variations. Crystal-like denotes a solid substance with a regular, repeating three-dimensional arrangement of its atoms or molecules. Different dosage forms such as tablets and oral solutions are utilized for various applications, including bronchospasm, allergic coryza, asthma, urticaria, among others.
The montelukast sodium market research report is one of a series of new reports from The Business Research Company that provides montelukast sodium market statistics, including montelukast sodium industry global market size, regional shares, competitors with a montelukast sodium market share, detailed montelukast sodium market segments, market trends, and opportunities, and any further data you may need to thrive in the montelukast sodium industry. This montelukast sodium market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The montelukast sodium market size has grown strongly in recent years. It will grow from $3.86 billion in 2024 to $4.24 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing respiratory disorders, an aging population, rising air pollution levels, growing awareness and education, and expansion in emerging markets.
The montelukast sodium market size is expected to see strong growth in the next few years. It will grow to $6.12 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to approval and launch, clinical studies, patent expiry, regulatory changes, and physician prescribing patterns. Major trends in the forecast period include increased generic competition, a shift towards combination therapies, expansion in emerging markets, a focus on pediatric use, and digital health solutions.
The growing prevalence of asthma is expected to drive the expansion of the montelukast sodium market in the coming years. Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to recurring episodes of wheezing, shortness of breath, chest tightness, and coughing. The rising incidence of asthma is attributed to factors such as environmental pollution, exposure to allergens, genetic factors, urbanization, lifestyle changes, and respiratory infections. Montelukast sodium, a leukotriene receptor antagonist, is used in asthma treatment to prevent and control symptoms by blocking the action of leukotrienes, which are responsible for airway inflammation and constriction. For example, in July 2024, the American Lung Association, a US-based health organization, reported that in 2022, around 44.2 million Americans, or 13.5% of the population, were diagnosed with asthma. Therefore, the increasing prevalence of asthma is fueling the growth of the montelukast sodium market.
Leading companies in the montelukast sodium market are introducing new drugs, such as over-the-counter (OTC) generic medications, to offer more convenient treatment options for patients managing asthma and allergic rhinitis. OTC generic medications are drugs available without a prescription, typically sold in pharmacies or retail stores. For example, in July 2022, Dr. Reddy's Laboratories, a pharmaceutical company based in India, launched Fexofenadine HCL 180 mg and Pseudoephedrine HCl 240 mg in the US. This product provides temporary relief from nasal and sinus congestion caused by colds or allergies. It is equivalent to Allegra-D 24 HR, combining an antihistamine and nasal decongestant to alleviate symptoms such as sneezing, runny nose, itchy eyes, and sore throat. Available in pack sizes of 5, 10, and 15, it offers a high-quality, cost-effective solution for those seeking relief from upper respiratory discomfort.
In April 2023, SK Capital Partners LP, a US-based private investment firm, completed the acquisition of Apotex Pharmaceutical Holdings Inc. for an undisclosed sum. This acquisition bolsters SK Capital's presence in the pharmaceutical sector, granting it access to Apotex's extensive global operations, product portfolio, and skilled workforce. Apotex Pharmaceutical Holdings Inc., headquartered in Canada, is known for manufacturing montelukast sodium and engaging in commercial physical and biological research and development.
Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd
North America was the largest region in the montelukast sodium market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the montelukast sodium market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The montelukast sodium market consists of sales of monteluksast oral granules, chewable tablets, pill organizers, dosing spoons and syringes, and tablet packaging material. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Montelukast Sodium Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on montelukast sodium market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for montelukast sodium ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The montelukast sodium market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Crystal-like; Form-less Or Amorphous
- 2) By Dosage Form: Tablets; Oral Solutions
- 3) By Application: Bronchospasm; Allergic Coryza; Asthma; Urticaria; Other Applications
- Subsegments:
- 1) By Crystal-Like: Monohydrate Crystal; Anhydrous Crystal; Spherical Crystals; Needle-Like Crystals; Polycrystalline Montelukast Sodium
- 2) By Form-Less Or Amorphous: Amorphous Powder; Amorphous Granules; Non-Crystalline Montelukast Sodium
- Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi Aventis SA; Teva Pharmaceuticals USA Inc.; Hetero Labs Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Montelukast Sodium Market Characteristics
3. Montelukast Sodium Market Trends And Strategies
4. Montelukast Sodium Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Montelukast Sodium Growth Analysis And Strategic Analysis Framework
- 5.1. Global Montelukast Sodium PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Montelukast Sodium Market Growth Rate Analysis
- 5.4. Global Montelukast Sodium Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Montelukast Sodium Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Montelukast Sodium Total Addressable Market (TAM)
6. Montelukast Sodium Market Segmentation
- 6.1. Global Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Crystal-like
- Form-less or Amorphous
- 6.2. Global Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablets
- Oral Solutions
- 6.3. Global Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bronchospasm
- Allergic Coryza
- Asthma
- Urticaria
- Other Applications
- 6.4. Global Montelukast Sodium Market, Sub-Segmentation Of Crystal-Like, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monohydrate Crystal
- Anhydrous Crystal
- Spherical Crystals
- Needle-Like Crystals
- Polycrystalline Montelukast Sodium
- 6.5. Global Montelukast Sodium Market, Sub-Segmentation Of Form-Less Or Amorphous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Amorphous Powder
- Amorphous Granules
- Non-Crystalline Montelukast Sodium
7. Montelukast Sodium Market Regional And Country Analysis
- 7.1. Global Montelukast Sodium Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Montelukast Sodium Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Montelukast Sodium Market
- 8.1. Asia-Pacific Montelukast Sodium Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Montelukast Sodium Market
- 9.1. China Montelukast Sodium Market Overview
- 9.2. China Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Montelukast Sodium Market
- 10.1. India Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Montelukast Sodium Market
- 11.1. Japan Montelukast Sodium Market Overview
- 11.2. Japan Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Montelukast Sodium Market
- 12.1. Australia Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Montelukast Sodium Market
- 13.1. Indonesia Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Montelukast Sodium Market
- 14.1. South Korea Montelukast Sodium Market Overview
- 14.2. South Korea Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Montelukast Sodium Market
- 15.1. Western Europe Montelukast Sodium Market Overview
- 15.2. Western Europe Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Montelukast Sodium Market
- 16.1. UK Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Montelukast Sodium Market
- 17.1. Germany Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Montelukast Sodium Market
- 18.1. France Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Montelukast Sodium Market
- 19.1. Italy Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Montelukast Sodium Market
- 20.1. Spain Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Montelukast Sodium Market
- 21.1. Eastern Europe Montelukast Sodium Market Overview
- 21.2. Eastern Europe Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Montelukast Sodium Market
- 22.1. Russia Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Montelukast Sodium Market
- 23.1. North America Montelukast Sodium Market Overview
- 23.2. North America Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Montelukast Sodium Market
- 24.1. USA Montelukast Sodium Market Overview
- 24.2. USA Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Montelukast Sodium Market
- 25.1. Canada Montelukast Sodium Market Overview
- 25.2. Canada Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Montelukast Sodium Market
- 26.1. South America Montelukast Sodium Market Overview
- 26.2. South America Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Montelukast Sodium Market
- 27.1. Brazil Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Montelukast Sodium Market
- 28.1. Middle East Montelukast Sodium Market Overview
- 28.2. Middle East Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Montelukast Sodium Market
- 29.1. Africa Montelukast Sodium Market Overview
- 29.2. Africa Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Montelukast Sodium Market Competitive Landscape And Company Profiles
- 30.1. Montelukast Sodium Market Competitive Landscape
- 30.2. Montelukast Sodium Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi Aventis SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Teva Pharmaceuticals USA Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Hetero Labs Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Montelukast Sodium Market Other Major And Innovative Companies
- 31.1. Sun Pharma Industries Ltd.
- 31.2. Aurobindo Pharma Limited
- 31.3. Cipla Inc.
- 31.4. Intas Pharmaceuticals Ltd.
- 31.5. Seqens Group
- 31.6. Sanyo Chemical Industries Ltd.
- 31.7. Morepen Laboratories
- 31.8. Neuland Laboratories Ltd.
- 31.9. Medopharm Private Ltd.
- 31.10. BEC Chemicals Pvt. Ltd
- 31.11. Delmar Chemicals Inc.
- 31.12. Kimia Biosciences Ltd.
- 31.13. Ortin Laboratories Ltd.
- 31.14. MSN Laboratories Pvt Ltd.
- 31.15. Vamsi Labs Ltd.
32. Global Montelukast Sodium Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Montelukast Sodium Market
34. Recent Developments In The Montelukast Sodium Market
35. Montelukast Sodium Market High Potential Countries, Segments and Strategies
- 35.1 Montelukast Sodium Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Montelukast Sodium Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Montelukast Sodium Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
